Sun Pharma

Sun Pharma is one of the largest pharmaceutical companies in India and operates globally. Sun Pharma utilizes biotechnology in certain aspects of its operations, primarily in the development and manufacturing of biologics. Biologics are a class of drugs that are derived from living organisms, such as proteins, antibodies, or nucleic acids. They are typically produced using biotechnological processes.

Sun Pharma has invested in building biologics capabilities and has a dedicated division called Sun Pharma Advanced Research Company (SPARC) that focuses on the research and development of innovative biologic drugs. SPARC is involved in developing novel drug delivery platforms, including biologics, peptides, and specialty generics.

Furthermore, Sun Pharma has collaborations and partnerships with other biotechnology companies and research institutions to leverage their expertise in biotech research and development. These collaborations can involve various aspects of biotechnology, such as genetic engineering, protein expression, and bioprocessing.

By incorporating biotechnology into its operations, Sun Pharma aims to expand its product portfolio to include biologics and leverage the potential of biotechnology in developing innovative therapies for various diseases.

Founded: 1983; 40 years ago
Founder: Dilip Shanghvi
Headquarters: Mumbai, India

Key people: Dilip Shanghvi (MD)

Website: https://sunpharma.com/